Skip to main content
Clinical Trials/NCT03495791
NCT03495791
Completed
Not Applicable

Web (YouTube) Based Educational Intervention to Improve Patient-Physician Awareness of Cardiovascular Risk in Rheumatoid Arthritis.

Rush University Medical Center1 site in 1 country300 target enrollmentOctober 31, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rheumatoid Arthritis
Sponsor
Rush University Medical Center
Enrollment
300
Locations
1
Primary Endpoint
Heart Disease Knowledge Questionnaire
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study will provide an educational intervention through means of a video to educate subjects on the risk of cardiovascular health on Rheumatoid arthritis.

Detailed Description

Subjects will be randomized into an interventional group and non-interventional group. Both groups will perform several surveys before an educational intervention may be given. Both Groups will come back 3 months post visit to complete additional surveys.

Registry
clinicaltrials.gov
Start Date
October 31, 2016
End Date
December 31, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical Diagnoses of Rheumatoid Arthritis of at least 3 months by a Rheumatologist

Exclusion Criteria

  • Inability to communicate in English.

Outcomes

Primary Outcomes

Heart Disease Knowledge Questionnaire

Time Frame: 3 Months

30 items survey completed at baseline (pre-intervention, post intervention), and 3 month follow-up. Change in cardiovascular knowledge at 3 months and baseline (post-intervention) will be measured against baseline pre-intervention values.

Heart Disease Fact Questionnaire

Time Frame: 3 Months

13 items survey completed at baseline (pre-intervention, post intervention), and 3 month follow-up. Change in cardiovascular awareness at 3 months and baseline (post-intervention) will be measured against baseline pre-intervention values.

Secondary Outcomes

  • Cholesterol(1 year)
  • Statues of Hyperlipidemia treatment(1 Year)

Study Sites (1)

Loading locations...

Similar Trials